Citation Impact
Citing Papers
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
2006
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Randomized placebo‐controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy
2001
Effects of Testosterone Replacement in Hypogonadal Men1
2000
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis
2007 StandoutNobel
Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men
2004 Standout
Spinal-cord injury
2002 Standout
Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.
1994
Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis
2001
Position Stand on Androgen and Human Growth Hormone Use
2009
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Effects of Transdermal Testosterone on Lipids and Vascular Reactivity in Older Men With Low Bioavailable Testosterone Levels
2002
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
2010
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
2013
Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies
2004
Effects of metformin and ethinyl estradiol–cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome
2005
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
2011
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
1994
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study
1999
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study
2001
Aging‐Related Decline of Gonadal Function in Healthy Men: Correlation with Body Composition and Lipoproteins
2000
Androgen deficiency in aging men: Role of testosterone replacement therapy
2000
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Polycystic Ovary Syndrome
2005 Standout
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
2009
Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point
2013 Standout
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
2001
Bone Accretion in Adolescents Using the Combined Estrogen and Progestin Transdermal Contraceptive Method Ortho Evra: A Pilot Study
2009
Polycystic Ovary Syndrome
2004
The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
2002
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
2009
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Adverse Lipid and Coronary Heart Disease Risk Profiles in Young Women with Polycystic Ovary Syndrome: Results of a Case-Control Study
1998
Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)
2005
Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age
2001
Polycystic ovary syndrome
2016 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
European Guidelines for Obesity Management in Adults
2015 Standout
Prevention of chronic alcohol and nicotine-induced azospermia, sterility and decreased libido, by a novel tri-substituted benzoflavone moiety from Passiflora incarnata Linneaus in healthy male rats
2002
Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin
2001
Oral Testosterone Supplementation Increases Muscle and Decreases Fat Mass in Healthy Elderly Males With Low-Normal Gonadal Status
2003 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Long-term health consequences of PCOS
2002
Polycystic Ovarian Syndrome (PCOS): A Significant Contributor to The Overall Burden of Type 2 Diabetes in Women
2007
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Vascular Dysfunction and Metabolic Parameters in Polycystic Ovary Syndrome
2005
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
2003
The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study
2002
Testosterone and obesity
2015
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study
2007
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
2001
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Passiflora: a review update
2004 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome
2004
Androgens and Coronary Artery Disease
2003
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
2002 Standout
The association of hypotestosteronemia with coronary artery disease in men.
1994
Metabolic Changes in Persons After Spinal Cord Injury
2000
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
1995
The Metabolic Syndrome
2008 Standout
An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
1992
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
2012
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
2012
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
2000 Standout
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women
2000
Endogenous Sex Hormones and Cardiovascular Disease in Men
2003
Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
1996
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
2005
Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia
2010
Works of M Srzednicki being referenced
Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-l in postmenopausal women
1992
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction
1989
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
1991
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease
1995
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
1996
[Serum estradiol level in men with acute myocardial infarction].
1986
The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone) and coronary arteriosclerosis in men: The lower the androgens, the higher the coronary score of arteriosclerosis
1999